Pharmacokinetics and metabolism of irinotecan combined with capecitabine in patients with advanced colorectal cancer.

Czejka, Martin; Schueller, Johannes; Hauer, Katharina; Ostermann, Eva

Czejka, Martin; Schueller, Johannes; Hauer, Katharina; Ostermann, Eva.

Affiliation

Czejka M; Department of Clinical Pharmacy and Diagnostics, Faculty of Life Sciences, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria. martin.czejka@univie.ac.at

Anticancer Res ; 25(4): 2985-90, 2005.

Article in En | MEDLINE | ID: mdl-16080556

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics; Colorectal Neoplasms/metabolism; Aged; Antineoplastic Combined Chemotherapy Protocols/blood; Camptothecin/administration & dosage; Camptothecin/analogs & derivatives; Camptothecin/blood; Camptothecin/pharmacokinetics; Capecitabine; Colorectal Neoplasms/blood; Colorectal Neoplasms/drug therapy; Deoxycytidine/administration & dosage; Deoxycytidine/analogs & derivatives; Deoxycytidine/blood; Deoxycytidine/pharmacokinetics; Drug Interactions; Female; Fluorouracil/analogs & derivatives; Glucuronides/blood; Glucuronides/pharmacokinetics; Humans; Irinotecan; Male; Middle Aged; Prodrugs/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Anticancer Res Year: 2005 Type: Article Affiliation country: Austria

Search on Google

Add to My VHL

XML

PubMed Links